Tau positron emission tomographic imaging in aging and early Alzheimer disease
about
Untangling tau imagingA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersCharacteristics of Tau and Its Ligands in PET ImagingHierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.Cerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy.Future Directions in Imaging Neurodegeneration.Cognitive resilience in clinical and preclinical Alzheimer's disease: the Association of Amyloid and Tau Burden on cognitive performance.Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's DiseaseTumor necrosis factor α Inhibition for Alzheimer's Disease.Tau PET imaging: present and future directions.Screening for mild cognitive impairment: If not now, when?Labeling Pathological Tau: An Important Quest for the Unknown.Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain.An Alzheimer's Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults.18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's diseaseTherapy and clinical trials in frontotemporal dementia: past, present, and future.A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease.Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [11C]PBB3-PET studyAV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.Repetitive head impact exposure and later-life plasma total tau in former National Football League players.PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain NetworksRelationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.Distinct white matter injury associated with medial temporal lobe atrophy in Alzheimer's versus semantic dementia.PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid BiomarkersCurrent Understanding of Neurodegenerative Diseases Associated With the Protein Tau.AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure.Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study.Alzheimer Disease: Scientific Breakthroughs and Translational Challenges.Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.Mapping Neurodegenerative Disease Onset and Progression.Defining imaging biomarker cut points for brain aging and Alzheimer's disease.Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.Molecular and cellular pathophysiology of preclinical Alzheimer's disease.Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.
P2860
Q26739091-25A3296D-CB20-42EA-BEEE-507EFA9BA01FQ26745508-1EAF8B6E-1C81-4AD7-8189-3B09FD175221Q26769952-C7D3C010-CC40-4C54-9E90-142A9767F559Q30100986-354F0813-21A8-431E-807D-DE67F0AA6667Q30275833-87CE1CA5-2617-46B9-A914-2C6B2D68CB93Q31162702-23E8E6FB-4209-4422-804A-924880A6C848Q33563786-ABA1A5FD-00D8-4B2C-BEAD-A0CFBEEFEDB1Q33695122-76A0210B-5C2D-4858-B8FF-C5A2F8B25DB3Q33704278-EAC99BD6-56AC-49E0-9CA0-0B3FCC960715Q34680852-048B2605-6192-4804-962F-4D7B761EF4C9Q36415014-8FC1FC9A-3E9D-43CB-A97D-96AF8AA6C6EEQ36970036-CEC2857F-0389-4560-99BA-5C3B09867DB8Q37063163-C2B22833-2AE2-4164-A414-F643BE92D468Q37096041-88ABAA68-D59F-4C9C-ABD5-83013125F716Q37096748-4ACDCB36-1FD7-4E3C-B41F-48EC052A9CFFQ37198563-12E4E4C9-CA83-4F7C-9BED-88525A8D524BQ37220632-AB86B7CA-B693-48AF-97CF-1ACA9D4011BEQ37294936-2976C789-6DFD-41A2-A54C-D0D3EA874AD4Q37566888-990189D3-FA33-4448-BE6D-D93EBCF186FFQ37590389-93E5E9D5-6158-4B1E-BC55-8E5AF2703498Q37600680-054DD821-9C8D-4900-BC31-808642F451DAQ37633577-D7163077-B0C3-4C76-8E3E-77707DE8AB4EQ37645272-3792D525-CF2D-4E10-8475-659C44032D9CQ37718557-1712559A-C41B-4129-9964-313426339326Q37731710-5AD7DD3C-6E08-4D35-8996-F96AD8689F95Q37731919-EB140EB8-4AFA-436B-B01A-AE71409CCBA8Q37739881-BC53B4FE-D885-48DA-A6B6-6441FC2671EAQ37739887-862086B3-608A-48E1-8752-4DD4FCA2264FQ38383420-3F4187D6-A52D-414F-9046-76AAC27E6C45Q38628805-D1FBEAE2-B1D4-42D2-BC24-F07083716DDEQ38640294-CBE7EF96-275A-4A1D-A19A-941CFDD00F3BQ38653494-EBE6BB94-AB1D-4E3E-B3C4-0C909FFA01F8Q38659171-68CFA878-9435-4808-98F7-4900F7DE26C0Q38675107-E2A5288E-05F6-4A2B-B7D6-020958477EE4Q38739937-F5229C1B-9663-4752-B244-8347DA8FC257Q38746445-613E2525-E606-4DD7-8B2A-D229F1964BCBQ38803637-3C247EB4-3658-4D95-8A41-9F15ECE03F12Q38812890-D3BB6228-E061-4C21-9E82-1AF7FCC5388FQ38836004-45C96DE9-CE82-4E18-982C-FB68D2B4A43EQ38896981-AD1D0BF8-25D9-4E6C-A6E6-18BF0FB32FA6
P2860
Tau positron emission tomographic imaging in aging and early Alzheimer disease
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tau positron emission tomographic imaging in aging and early Alzheimer disease
@ast
Tau positron emission tomographic imaging in aging and early Alzheimer disease
@en
type
label
Tau positron emission tomographic imaging in aging and early Alzheimer disease
@ast
Tau positron emission tomographic imaging in aging and early Alzheimer disease
@en
prefLabel
Tau positron emission tomographic imaging in aging and early Alzheimer disease
@ast
Tau positron emission tomographic imaging in aging and early Alzheimer disease
@en
P2093
P2860
P50
P356
P1433
P1476
Tau positron emission tomographic imaging in aging and early Alzheimer disease
@en
P2093
Bradford Dickerson
Daniel Yokell
Dorene Rentz
Elizabeth Mormino
Gad Marshall
J Alex Becker
Jasmeer Chhatwal
Jonathan Alverio
Keith A Johnson
P2860
P304
P356
10.1002/ANA.24546
P577
2015-10-27T00:00:00Z